MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer

Pedroza‑Torres,Abraham; Campos‑Parra,Alma  D.; Millan‑Catalan,Oliver; Loissell‑Baltazar,Yahir  A.; Zamudio‑Meza,Horacio; Cantú de León,David; Montalvo‑Esquivel,Gonzalo; Isla‑Ortiz,David; Herrera,Luis  A.; Ángeles‑Zaragoza,Óscar; Robelo‑Romero,Guadalupe; Herrera‑Gómez,Ángel; Pérez‑Plasencia,Carlos

doi:10.3892/or.2018.6219

MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer

Authors:
- Abraham Pedroza‑Torres
- Alma D. Campos‑Parra
- Oliver Millan‑Catalan
- Yahir A. Loissell‑Baltazar
- Horacio Zamudio‑Meza
- David Cantú de León
- Gonzalo Montalvo‑Esquivel
- David Isla‑Ortiz
- Luis A. Herrera
- Óscar Ángeles‑Zaragoza
- Guadalupe Robelo‑Romero
- Ángel Herrera‑Gómez
- Carlos Pérez‑Plasencia
View Affiliations

Affiliations: Cancer Genomics Group, National Cancer Institute of Mexico, México City 14080, Mexico, Gynecology Functional Department, National Cancer Institute of Mexico, México City 14080, Mexico, Cancer Research Unit, National Cancer Institute of Mexico, México City 14080, Mexico, Radiotherapy Department, National Cancer Institute of Mexico, México City 14080, Mexico, Deputy Director, National Cancer Institute of Mexico, México City 14080, Mexico
Published online on: January 18, 2018 https://doi.org/10.3892/or.2018.6219
Pages: 1532-1540

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer (CC) is one of the most common cancers diagnosed in women worldwide, and it is estimated that ~500,000 new patients are diagnosed with cervical cancer annually and that ~270,000 deaths occur each year. Patients with cervical cancer are treated with different radiotherapy schedules, either alone or with adjuvant chemotherapy. Unfortunately, nearly 50% of all patients with cervical cancer do not respond to standard treatment due to tumor radioresistance. In this scenario, several microRNAs (miRNAs) have been associated with the acquisition of the radioresistance phenotype. The aim of the present study was to evaluate the possible role of miR‑125a in the acquisition of radioresistance in cervical cancer. The expression of miR‑125a was assessed by means of RT‑qPCR in 30 cervical cancer samples from patients receiving standard treatment and 3 induced radioresistant cervical cancer cell lines. In addition, we employed miR‑125a mimics and inhibitors to evaluate its function in the induction of radioresistance. We showed that miR‑125a was downregulated in patients with cervical cancer who did not respond to standard treatment. Concordantly, radioresistant SiHa, CaSki and HeLa cell lines had low levels of miR‑125a with respect to the sensitive cell lines. Finally, we demonstrated that overexpression of miR‑125a sensitized cervical cancer cells to radiation therapy through the downregulation of CDKN1A. Our data corroborate previously published studies in which it was demonstrated that miRNAs could play a role in the regulation of the process of radioresistance. Additionally, we showed that overexpression of miR‑125a could be used as a radioresistance biomarker in patients with cervical cancer.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancerstatistics, 2012. CA Cancer J Clin. Mar;65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Delaney G, Jacob S, Featherstone C and Barton M: The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 104:1129–1137. 2005. View Article : Google Scholar : PubMed/NCBI
3	Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY and Pecorelli S: Carcinoma of the cérvix uteri. Int J Gynaecol Obstet. 83 Suppl 1:S41–S78. 2003. View Article : Google Scholar
4	Zhang B, Chen J, Ren Z, Chen Y, Li J, Miao X, Song Y, Zhao T, Li Y, Shi Y, et al: A specific miRNA signature promotes radioresistance of human cervical cancer cells. Cancer Cell Int. 13:1182013. View Article : Google Scholar : PubMed/NCBI
5	Yang CX, Zhang SM, Li J, Yang B, Ouyang W, Mei ZJ, Chen J, Dai J, Ke S, Zhou FX, et al: MicroRNA-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin. Oncol Lett. 12:4983–4990. 2016. View Article : Google Scholar : PubMed/NCBI
6	Pedroza-Torres A, Fernández-Retana J, Peralta-Zaragoza O, Jacobo-Herrera N, Cantú de Leon D, Cerna-Cortés JF, Lopez-Camarillo C and Pérez-Plasencia C: A microRNA expression signature for clinical response in locally advanced cervical cancer. Gynecol Oncol. 142:557–565. 2016. View Article : Google Scholar : PubMed/NCBI
7	Bousquet M, Harris MH, Zhou B and Lodish HF: MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA. 107:pp. 21558–21563. 2010; View Article : Google Scholar : PubMed/NCBI
8	Hulanicka M, Garncarz M, Parzeniecka-Jaworska M and Jank M: Plasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds. BMC Vet Res. 10:2052014. View Article : Google Scholar : PubMed/NCBI
9	Cowden Dahl KD, Dahl R, Kruichak JN and Hudson LG: The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia. 11:1208–1215. 2009. View Article : Google Scholar : PubMed/NCBI
10	Betel D, Wilson M, Gabow A, Marks DS and Sander C: The microRNA.org resource: Targets and expression. Nucleic Acids Res. 36:D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
11	Asgharian A, Banan M and Najmabadi H: Optimizing a lipocomplex-based gene transfer method into HeLa cell line. Cell J. 15:372–377. 2014.PubMed/NCBI
12	Li G, Qiu Y, Su Z, Ren S, Liu C, Tian Y and Liu Y: Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing. PLoS One. 8:e844862013. View Article : Google Scholar : PubMed/NCBI
13	Guo W, Xie L, Zhao L and Zhao Y: mRNA and microRNA expression profiles of radioresistant NCI-H520 non-small cell lung cancer cells. Mol Med Rep. 12:1857–1867. 2015. View Article : Google Scholar : PubMed/NCBI
14	McDermott N, Meunier A, Wong S, Buchete V and Marignol L: Profiling of a panel of radioresistant prostate cancer cells identifiesde regulation of key miRNAs. Clin Transl Radiat Oncol. 2:63–68. 2017. View Article : Google Scholar
15	Maier P, Hartmann L, Wenz F and Herskind C: Cellular pathways in response to ionizin gradiation and their target ability for tumor radio sensitization. Int J Mol Sci. 17:1022016. View Article : Google Scholar :
16	Ishigami T, Uzawa K, Higo M, Nomura H, Saito K, Kato Y, Nakashima D, Shiiba M, Bukawa H, Yokoe H, et al: Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer. 120:2262–2270. 2007. View Article : Google Scholar : PubMed/NCBI
17	Skvortsova I, Skvortsov S, Stasyk T, Raju U, Popper BA, Schiestl B, Guggenberg Ev, Neher A, Bonn GK, Huber LA and Lukas P: Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics. 8:4521–4533. 2008. View Article : Google Scholar : PubMed/NCBI
18	Moskwa P, Zinn PO, Choi YE, Shukla SA, Fendler W, Chen CC, Lu J, Golub TR, Hjelmeland A and Chowdhury D: A functional screen identifies miRs that induce radioresistance in glioblastomas. Mol Cancer Res. 12:1767–1778. 2014. View Article : Google Scholar : PubMed/NCBI
19	Shiiba M, Shinozuka K, Saito K, Fushimi K, Kasamatsu A, Ogawara K, Uzawa K, Ito H, Takiguchi Y and Tanzawa H: MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma. Br J Cancer. 108:1817–1821. 2013. View Article : Google Scholar : PubMed/NCBI
20	Fan Z, Cui H, Xu X, Lin Z, Zhang X, Kang L, Han B, Meng J, Yan Z, Yan X and Jiao S: MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancerbytargeting STAT3. Oncotarget. 6:25266–25280. 2015. View Article : Google Scholar : PubMed/NCBI
21	Fan Z, Cui H, Yu H, Ji Q, Kang L, Han B, Wang J, Dong Q, Li Y, Yan Z, et al: MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. Oncogenesis. 5:e1972016. View Article : Google Scholar : PubMed/NCBI
22	Kraus A, Gross MW, Knuechel R, Münkel K, Neff F and Schlegel J: Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53. J Neurosurg. 93:863–872. 2000. View Article : Google Scholar : PubMed/NCBI
23	Kokunai T, Urui S, Tomita H and Tamaki N: Overcoming of radioresistance in human gliomas by p21WAF1/CIP1 antisense oligonucleotide. J Neurooncol. 51:111–119. 2001. View Article : Google Scholar : PubMed/NCBI